Should cost effectiveness analyses for NICE always consider future unrelated medical costs?

Pieter van Baal, Alec Morton, Werner Brouwer, David Meltzer, Sarah Davis

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)
59 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Should cost effectiveness analyses for NICE always consider future unrelated medical costs?'. Together they form a unique fingerprint.

Business & Economics

Medicine & Life Sciences